Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
Pigment Cell & Melanoma Research · 2022-11 · 35 (6) · 605-612
DOI: 10.1111/pcmr.13058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 12.08.2022. Verfasst von Li Luo und 44 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, MicroRNAs. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
It is unclear why some melanomas aggressively metastasize while others remain indolent. Available studies employing multi‐omic profiling of melanomas are based on large primary or metastatic tumors. We examine the genomic landscape of early‐stage melanomas diagnosed prior to the modern era of immunological treatments. Untreated cases with Stage II/III cutaneous melanoma were identified from institutions throughout the United States, Australia and Spain. FFPE tumor sections were profiled for mutation, methylation and microRNAs. Preliminary results from mutation profiling and clinical pathologic correlates show the distribution of four driver mutation sub‐types: 31% BRAF; 18% NRAS; 21% NF1; 26% Triple Wild Type. BRAF mutant tumors had younger age at diagnosis, more associated nevi, more tumor infiltrating lymphocytes, and fewer thick tumors although at generally more advanced stage. NF1 mutant tumors were frequent on the head/neck in older patients with severe solar elastosis, thicker tumors but in earlier stages. Triple Wild Type tumors were predominantly male, frequently on the leg, with more perineural invasion. Mutations in TERT, TP53, CDKN2A and ARID2 were observed often, with TP53 mutations occurring particularly frequently in the NF1 sub‐type. The InterMEL study will provide the most extensive multi‐omic profiling of early‐stage melanoma to date. Initial results demonstrate a nuanced understanding of the mutational and clinicopathological landscape of these early‐stage tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Incyte, Wilmington, Delaware, USA.
- Department of Pathology and Laboratory Science, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- British Columbia Cancer Research Center, Vancouver, British Columbia, Canada.
- Langone Cancer Center, New York University, New York, New York, USA.
ORCID-Profile: Irene Orlow, Richard A Scolyer, Matthew Schwartz, Sheri Holmen, Marianne Berwick
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- NIEHS NIH HHS
- NIGMS NIH HHS
- Char and Chuck Fowler Family Foundation
- National Cancer Institute
- National Health and Medical Research Council
- National Institute of General Medical Sciences
Zitieren
APA
Luo, L., Shen, R., Arora, A., Orlow, I., Busam, K. J., Lezcano, C., Lee, T. K., Hernando, E., Gorlov, I., Amos, C., Ernstoff, M. S., Seshan, V. E., Cust, A. E., Wilmott, J., Scolyer, R. A., Mann, G., Nagore, E., Funchain, P., Ko, J., …, & InterMEL (2022). Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study. Pigment Cell & Melanoma Research, 35(6), 605-612. https://doi.org/10.1111/pcmr.13058
Vancouver
Luo L, Shen R, Arora A, Orlow I, Busam KJ, Lezcano C, et al. Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study. Pigment Cell & Melanoma Research. 2022;35(6):605-612. doi:10.1111/pcmr.13058
BibTeX
@article{Luo2022,
author = {Luo, Li and Shen, Ronglai and Arora, Arshi and Orlow, Irene and Busam, Klaus J and Lezcano, Cecilia and Lee, Tim K and Hernando, Eva and Gorlov, Ivan and Amos, Christopher and Ernstoff, Marc S and Seshan, Venkatraman E and Cust, Anne E and Wilmott, James and Scolyer, Richard A and Mann, Graham and Nagore, Eduardo and Funchain, Pauline and Ko, Jennifer and Ngo, Peter and Edmiston, Sharon N and Conway, Kathleen and Googe, Paul B and Ollila, David and Lee, Jeffrey E and Fang, Shenying and Rees, Judy R and Thompson, Cheryl L and Gerstenblith, Meg and Bosenberg, Marcus and Gould Rothberg, Bonnie and Osman, Iman and Saenger, Yvonne and Reynolds, Adam Z and Schwartz, Matthew and Boyce, Tawny and Holmen, Sheri and Brunsgaard, Elise and Bogner, Paul and Kuan, Pei Fen and Wiggins, Charles and Thomas, Nancy E and Begg, Colin B and Berwick, Marianne and InterMEL, InterMEL},
title = {Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study},
journal = {Pigment Cell & Melanoma Research},
year = {2022},
volume = {35},
number = {6},
pages = {605--612},
doi = {10.1111/pcmr.13058}
}
EUVIMED